Why the study?
Does pulmonary thromboendarterectomy successfully treat chronic thromboembolic pulmonary hypertension in pediatric patients?
Does pulmonary thromboendarterectomy successfully treat chronic thromboembolic pulmonary hypertension in pediatric patients?
Pulmonary thromboendarterectomy can be successfully performed as a therapeutic option in pediatric patients with chronic thromboembolic pulmonary hypertension.
Answers are grounded in this paper and cite their sources.
PTE may be feasible in select pediatric CTEPH cases; hypothesis-generating and should not yet change practice.
Kumbasar U, Aypar E, Karagöz T, Demircin M, Doğan R. Pulmonary thromboendarterectomy in pediatric patients: Report of three cases. Turk J Pediatr 2018; 60: 604-607. Chronic thromboembolic pulmonary hypertension (CTEPH), which occurs due to impartial resolution of the pulmonary thrombus, is a rare type of pulmonary hypertension. However, most patients have an excellent long-term survival following pulmonary thromboendarterectomy (PTE). Pulmonary emboli and associated CTEPH is unusual in the pediatric population and is mostly reveals an underlying thrombophilic state. PTE is also recognized as the best therapeutic option in this subgroup of patients. In this case series, we report three young patients who had successfully undergone PTE due to pulmonary emboli and associated CTEPH.
No takes yet. Share an insight, caveat, or question.
Kumbasar et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: